|
2026
|
G/S
|
Medical apparatuses, namely, catheters, combination drug delivery devices sold empty, infusion ap... |
|
|
G/S
|
Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmace... |
|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide access ... |
|
|
G/S
|
Genetically modified cells, genome editing reagents, and biological preparations, namely, viral v... |
|
|
Invention
|
Methods for treating or preventing asthma by administering an il-4r antagonist.
The present inve... |
|
|
Invention
|
Psca car-t cells.
The technology relates generally to the field of immunology and relates in par... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
|
G/S
|
Promoting and supporting education and recognition initiatives in the science, technology, engine... |
|
|
Invention
|
Method for generating high affinity antibodies.
The present disclosure relates to a method for i... |
|
|
G/S
|
Providing scientific information, news, and commentary in the field of pharmaceuticals; Providing... |
|
|
Invention
|
Intralesional administration of pd-1 inhibitors for treating skin cancer.
The disclosure relates... |
|
|
Invention
|
Medical device packaging and related methods.
According to one aspect of the disclosure, packagi... |
|
|
Invention
|
Systems and methods for identifying viral contaminants.
The present disclosure is directed to a ... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Competitive ligand binding assays.
Improved assays for the detection and optionally the quantifi... |
|
|
G/S
|
Live animals |
|
|
Invention
|
Devices and methods for overfilling drug containers.
Disclosed herein are methods for overfillin... |
|
|
Invention
|
Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies.
The present i... |
|
|
Invention
|
Method for predicting and modulating glycation of a protein.
Embodiments provide for methods of ... |
|
|
G/S
|
Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid mole... |
|
|
Invention
|
Cll-1 targeted immunotherapies.
The present disclosure provides improved CLL-1 targeting polypep... |
|
|
Invention
|
Crispr/cas screening platform to identify genetic modifiers of tau seeding or aggregation.
Cas-p... |
|
|
Invention
|
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector syst... |
|
|
Invention
|
Therapeutic strategies to reduce thrombotic risk in factor v leiden (fvl) carriers. Methods of re... |
|
|
Invention
|
Therapeutic strategies to reduce thrombotic risk in factor v leiden (fvl) carriers.
Methods of r... |
|
|
Invention
|
Tumor-targeted split il2 receptor agonists. The present disclosure relates to tumor-targeted spli... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neuromuscular, muscular, musculos... |
|
|
Invention
|
Non-human animals with humanized fc epsilon receptors that lack functional alpha-1, 3-galactosylt... |
|
|
Invention
|
Antibody-polynucleotide conjugates via inverse electron demand diels-alder reactions. Provided he... |
|
|
Invention
|
Modified mtm1 genes and uses thereof. MHCK7MHCK7, or a combination thereof. Also provided herein ... |
|
|
Invention
|
Non-human animals having modified immunoglobulin heavy chain constant region locus and uses there... |
|
|
Invention
|
Development of biolayer interferometry (bli) based double strand rna detection utilizing fhv b2 p... |
|
|
Invention
|
Methods for preventing artificial disulfide scrambling in non-reduced peptide mapping.
Methods f... |
|
|
Invention
|
Prostate-specific antigen peptides and uses thereof. The present disclosure provides isolated pep... |
|
|
Invention
|
Adoptive cellular therapy.
The invention provides improved compositions and methods for the trea... |
|
|
Invention
|
Otic drug delivery system and methods.
Disclosed herein are drug delivery devices including cath... |
|
|
Invention
|
Otic drug delivery system. Disclosed herein are drug delivery devices including catheter assembli... |
|
|
Invention
|
Methods for treating or preventing asthma by administering an il-4r antagonist.
Methods for trea... |
|
|
Invention
|
Treatment of parkinson's disease with sim bhlh transcription factor 2 (sim2) agonists.
The prese... |
|
|
Invention
|
Methods for characterizing a protein.
The present disclosure provides methods and systems for ch... |
|
|
Invention
|
Methods of making ultra-high concentrated protein formulations using lyophilization. The present ... |
|
|
Invention
|
Aav viral particles retargeted to egfr-expressing cancer cells. Provided herein are compositions ... |
|
|
Invention
|
Treatment of parkinson's disease with sim bhlh transcription factor 2 (sim2) agonists. The presen... |
|
|
Invention
|
Compositions and methods for detecting a biological contaminant.
Provided are compositions and m... |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide informa... |
|
|
Invention
|
Diels-alder conjugation methods.
Described herein are protein-payload conjugates and composition... |
|
|
Invention
|
Endoglycosidase-assisted peptide mapping.
Endoglycosidase-assisted peptide mapping workflow syst... |
|
|
Invention
|
Gprc5d x cd28 bispecific antibodies and methods of use thereof.
The present disclosure provides ... |
|
|
Invention
|
Gprc5d x cd28 bispecific antibodies and methods of use thereof. e.g.e.g., multiple myeloma). |
|
|
Invention
|
Methods of treating smarcb1-deficient cancers. e.g.e.g.e.g., an anti-PD-L1 antibody) to the subje... |
|
|
Invention
|
Treatment of aortic stenosis with inhibitors of alkaline phosphatase (alpl). The present disclosu... |
|
|
Invention
|
Treatment of rheumatoid arthritis with an il-6r antibody.
The present invention provides composi... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders... |
|
|
Invention
|
Sterilization method.
Embodiments of the present disclosure relate to systems and methods for th... |
|
|
Invention
|
Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof.
Non-h... |
|
|
Invention
|
Vegf antagonists and methods of use thereof.
The present disclosure relates to VEGF antagonists.... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment and/or prevention of diseases, namel... |
|
|
G/S
|
Syringes for medical purposes and for injections; Injection device for pharmaceuticals; Injection... |
|
|
Invention
|
Steroids and protein-conjugates thereof.
Described herein are protein steroid conjugates that ar... |
|
|
Invention
|
Bispecific anti-bcma x anti-cd3 antibodies and uses thereof.
B-cell maturation antigen (BCMA) is... |
|
2023
|
Invention
|
Drug-delivery device |
|
|
Invention
|
Aggregation-resistant variants of tdp-43.
Provided herein are TDP-43 variants in which a prion-l... |
|
|
Invention
|
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle... |
|
2022
|
Invention
|
Methods and compositions for modulating the activity of a dimerizing agent regulated immunomodula... |
